 random compar studi prophylact use trimethoprim-sulfamethoxazol versu netilmycin-metronidazol transrect prostat biopsi open random studi prophylact valu singl dose netilmycin-metronidazol versu trimethoprim-sulfamethoxazol prevent postop infect transrect prostat biopsi patient studi patient netilmycin-metronidazol trimethoprim-sulfamethoxazol bacteremia rate netilmycin-metronidazol group patient confid interv trimethoprim-sulfamethoxazol group confid interv none patient bacteremia symptomat urinari tract infect rate netilmycin-metronidazol group patient trimethoprim-sulfamethoxazol group trimethoprim-sulfamethoxazol cotrimoxazol choic antimicrobi prophylaxi patient undergo transrect prostat biopsi